PCDH1 Activators are a diverse group of chemical compounds that indirectly augment the functional activity of PCDH1 through various signaling pathways, primarily affecting cell-cell adhesion and signaling. Forskolin and IBMX both increase intracellular cAMP levels, which activates PKA, a kinase that phosphorylates various substrates, thereby potentially enhancing PCDH1's role in the formation and maintenance of cellular junctions. PMA functions as an activator of PKC, which plays a significant role in signal transduction for cell adhesion, where PCDH1 is a critical component. Sphingosine-1-phosphate (S1P) acts through its receptors to initiate signaling cascades that regulate cytoskeletal dynamics, which could lead to the strengthening of PCDH1-mediated cell connections. On the other hand, the flavonoid Genistein and the polyphenol EGCG modulate kinase activities, which might reduce competitive signaling and thus enhance PCDH1 function.
Continuing with this theme, LY294002 and U0126 alter the PI3K/Akt and MAPK/ERK pathways, respectively, pathways that are integral to cell survival, proliferation,and differentiation, which could indirectly enhance PCDH1's adhesive and communicative functions in cellular networks. Staurosporine, despite its general kinase inhibition, selectively lifts the inhibition on kinases that negatively regulate PCDH1 pathways, thereby potentially augmenting PCDH1's activity. Similarly, Thapsigargin increases intracellular calcium levels, which activates calcium-dependent signaling pathways, key in processes where PCDH1 is involved. Furthermore, A23187 directly elevates intracellular calcium, further potentiating the activation of calcium-dependent pathways crucial for cell adhesion and signaling dynamics associated with PCDH1. Lastly, Anandamide influences G-protein coupled receptor signaling, which has implications for PCDH1 in neuronal development, suggesting a broader context for the activation of PCDH1 beyond the typical adhesion-related roles, indicating a versatile potential for these activators in influencing PCDH1's function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly elevates intracellular cAMP levels, which in turn activates protein kinase A (PKA). PKA phosphorylates target proteins that can enhance the functional activity of PCDH1, involved in cell-cell adhesion and signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases (PDEs), leading to an increase in intracellular cAMP levels. Enhanced cAMP can activate PKA, indirectly enhancing PCDH1 activity related to cellular junctions. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in various cellular processes. PKC activation can lead to downstream effects that enhance PCDH1-mediated cell adhesion signaling pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
D-erythro-Sphingosine-1-phosphate (S1P) is a bioactive lipid that activates sphingosine-1-phosphate receptors, which can trigger intracellular signaling cascades, including those regulating cytoskeletal dynamics and cell-cell adhesion, potentially enhancing PCDH1 function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate is a potent antioxidant that can inhibit certain protein kinases, modifying signaling pathways and potentially enhancing PCDH1's role in intercellular connections within tissues. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, altering the PI3K/Akt signaling pathway. By modulating this pathway, it can influence cellular processes, possibly enhancing the functional activity of PCDH1. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor, but by selectively inhibiting certain kinases, it might lead to an enhancement of PCDH1 pathways by reducing negative regulatory influences. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a non-competitive inhibitor of the endoplasmic reticulum Ca2+ ATPase, leading to an increase in cytosolic calcium levels, which can activate calcium-dependent signaling pathways, indirectly enhancing PCDH1 activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can modulate the tyrosine kinase-dependent signaling pathways. This modulation can lead to an enhanced activity of PCDH1 by reducing competitive kinase activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, promoting the activation of calcium-dependent signaling pathways. This can enhance the function of PCDH1, which is important for cell adhesion and signaling. | ||||||